FTC sues main pharmacy advantage administrators over insulin price ranges The company introduced motion in opposition to Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of life-conserving insulin medications. Sanders quickly condemned the go in a press release Wednesday, noting https://kethek.com/